Vimarsana
Biggest News Aggregation in the World

Michael Feigh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Feigh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Feigh Today - Breaking & Trending Today

NeuroBo Pharmaceuticals' DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models Compared to Either Treatment, Alone - Vimarsana News

NeuroBo Pharmaceuticals' DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models Compared to Either Treatment, Alone

Published: May 22, 2024

NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical data suggests that DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist,...

Source: lelezard.com
Related Topics:
United KingdomMonika LewinskaSujin LeeHenrikb HansenMarshallh WoodworthAhyoung KimMichael FeighHoon JungMi Kyung KimYuna ChaeMichael MillerNeurobo PharmaceuticalsDonga St Research CenterMembers Of The Donga St Research CenterContract Research OrganizationExchange CommissionNeurobo Pharmaceuticals IncRx Communications GroupPrnewswire Neurobo Pharmaceuticals IncDonga St CoScientific ResearchSemaglutide Improves Liver FibrosisDemonstrates Additive Hepatoprotective EffectsEither TreatmentTwo Posters
NeuroBo to Present Latest Pre-Clinical Data on Cardiometabolic Assets, DA-1241 and DA-1726, Targeting MASH and Obesity, at Scientific Conferences in June - Vimarsana News

NeuroBo to Present Latest Pre-Clinical Data on Cardiometabolic Assets, DA-1241 and DA-1726, Targeting MASH and Obesity, at Scientific Conferences in June

Published: April 30, 2024

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomMichael FeighAhyoung KimMichael MillerYuna ChaeSu Jin LeeHoon JungHenrikb HansenMonika LewinskaSujin LeeShun JungMi Kyung KimMarshallh WoodworthNeurobo PharmaceuticalsAmerican Diabetes AssociationDonga St CoMembers Of The Donga St Research CenterNeurobo Pharmaceuticals IncDonga St Research CenterPrnewswire Neurobo Pharmaceuticals IncScientific ResearchContract Research OrganizationScientific SessionsHyung Heon Kim